Heidi W. Moore

Angela Casey, MD, relates her experiences addressing patients’ concerns about skin damage caused by blue light.

Tiffany Link, MD, PhD, reviews some strategies for addressing the specific needs and constraints of treating teenage patients with acne.

Jack S. Resneck Jr., MD, was inaugurated as the 177th president of the American Medical Association (AMA). He is a dermatologist, professor, and vice-chair of the Department of Dermatology at UC San Francisco.

For this year’s Acne Awareness Month, Savina Aneja, MD, talks with us about what she’s currently seeing in her practice–with treatment that now ranges from traditional to high tech.

Patient awareness of sun damage doesn’t always translate into safer sun practices, finds Lisa Nyanda-Manola, MD. She describes how she counsels her patients, especially those with skin of color, to protect themselves.

Esther Yoonah Kim, MD and her colleague, Andy Wongworawat, MD, discuss patient “support” as it encompasses emotional, physical, and financial aspects of care.

We speak with Charles Dunn, MD, about his experiences in a unique dermatology residency program offered by a nationwide clinic, Advanced Dermatology and Cosmetic Surgery.

The team at Dermatology Advisor will be reporting on the latest news and research conducted by leading experts in dermatology and presented at the 2022 American Academy of Dermatology Annual Meeting, being held live from March 25 through March 29 in Boston, Massachusetts.

Margareth Pierre-Louis, MD, MBA, spoke with us about patients’ expectations of convenient, on-demand care and how it will determine who survives in the digital health care environment.

Expert on vitiligo John E. Harris, MD, associate professor of dermatology at University of Massachusetts Medical School (UMMS) in Worcester, spoke with us about the skin disorder.

Moderna mRNA-1273-P301 study participants will now be asked to disclose information about their use of facial fillers.

The American Society for Dermatologic Surgery (ASDS) has released a new guidance regarding adverse events associated with the SARS-CoV-2 mRNA vaccine and dermal fillers.

Researchers evaluated the effect on skin-specific systemic lupus erythematosus disease activity using data pooled from the TULIP-1 and TULIP-2 trials.

Taste and smell disturbances are common symptoms of COVID-19, but they can also be caused by medications frequently prescribed by dermatologists.

Researchers evaluated the use of TNFis vs methotrexate in reducing the risk for progression to psoriatic arthritis in patients with psoriasis.

Observations and theories about the emergence of “COVID toes” in patients are discussed with Adam Friedman, MD, FAAD.

New registries have been established to capture emerging data on patients with psoriasis and atopic dermatitis who have COVID-19.

A study from Italy reports severe outcomes related to the COVID-19 infection in patients with chronic plaque psoriasis receiving immunosuppressive therapies.

The outbreak of COVID-19 affects the management of chronic dermatologic disease in those patients already receiving therapy and patients about to begin a new treatment.

An understanding of pathophysiology may serve to guide clinical decision making when using biologic agents during the COVID-19 pandemic.

The American Academy of Dermatology has established fluid protocols to protect clinicians and patients during the COVID-19 pandemic.

A panel of dermatologists outline how to implement a telehealth structure that allows for sustainable and scalable practice beyond the current crisis.

For insights on the effect of more vigilant personal hand hygiene and guidance on how best to maintain these practices while addressing concerns about skin disorders, we spoke with Joel Schlessinger, MD, a board-certified dermatologic surgeon.

In the absence of COVID-19-specific data, published research may serve to guide treatment with biologic agents in patients with psoriasis.

Repeated cycles of treatment with crisaborole may be necessary to achieve and maintain control of atopic dermatitis symptoms.

The American Academy of Dermatology (AAD) has canceled their 2020 annual meeting, which was scheduled to take place from March 20 to 24 in Denver, Colorado. The decision came in light of the restrictions placed on large gatherings, travel, and the closure of public facilities and businesses in an effort to curtail the coronavirus pandemic.

Kojic acid is surging in popularity for the treatment of melasma. Jared Jagdeo, MD, reviewed with us his experience treating his patients with kojic acid.

Eli Lilly agreed to buy biopharmaceutical company Dermira, Inc. for $18.75 a share, or approximately $1.1 billion in cash.

Researchers reported on the efficacy of secukinumab in patients with psoriatic arthritis and nail psoriasis and other elements of the disease, including radiographic progression.

Teledermatology offers near-immediate access to specialty medicine for underserved populations. Robert Stavert, MD, MBA, describes the successful physician-to-physician model his team employs at a safety net healthcare system.